Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer

Name: Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer
License: Public Domain

Mayo Clinic

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic pancreatic ductal adenocarcinoma, stage iv pancreatic cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 158235
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.